Asset Dedication LLC’s Insmed INSM Stock Holding History

Asset Dedication LLC’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-171	Closed	-$11.8K	–	1151
2024 Q4	$11.8K	Hold	171	–	–	﹤0.01%	741
2024 Q3	$12.5K	Buy	+171	New	+$12.6K	﹤0.01%	771

Other funds holding INSM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Asset Dedication LLC's INSM Position: Q1 2025 in Review

Asset Dedication LLC sold out of Insmed (INSM) in Q1 2025, closing a stake of 171 shares — an estimated $11.8K sold.

Asset Dedication LLC first reported a position in INSM in Q3 2024 and held it in 2 quarters. The position peaked at $12.5K in Q3 2024. 441 funds tracked by Wall St. Rank hold INSM as of Q1 2025.

Asset Dedication LLC reported no remaining Insmed position as of Q1 2025 after selling out during the quarter.
Asset Dedication LLC sold 171 Insmed shares in Q1 2025, an estimated $11.8K.
Asset Dedication LLC first reported a position in Insmed in Q3 2024 and held it in 2 quarters.
Asset Dedication LLC's Insmed position peaked at $12.5K in Q3 2024.
441 funds tracked by Wall St. Rank held Insmed as of Q1 2025.

Based on Asset Dedication LLC's 13F filing for Q1 2025, filed 1 May 2025.